Kintor Pharmaceutical Limited (9939.HK) Comparison with companies in other sectors?

Kintor Pharmaceutical Limited has a share price of 434.20M. You can analyze Kintor Pharmaceutical Limited (9939.HK) competitors across different market sectors through stock heatmaps.

What are 9939.HK's NET and operating margins?

Kintor Pharmaceutical Limited (9939.HK) operating margin is around 0.00, and net profit margin is approximately 0.00 as of the latest reports.

In what way does 9939.HK's earnings per share (EPS) trend reflect its financial momentum?

Kintor Pharmaceutical Limited (9939.HK) EPS is -0.39 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Kintor Pharmaceutical Limited is -5.46, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Kintor Pharmaceutical Limited?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Kintor Pharmaceutical Limited like P/E which is 0.00, P/B which is 2.85, and PEG which is 0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

Kintor Pharmaceutical Limited

9939.HK•HKSE

Healthcare

Biotechnology

HK$2.10

HK$-0.46(-17.97%)

Kintor Pharmaceutical Limited (9939.HK) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-0.39

P/E Ratio

-5.46

ROE

Net Margin

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$924.84M

Shares OutstandingTotal number of shares issued

$434.20M

Book Value/ShareNet worth per share

$0.69

Revenue/ShareAnnual revenue per share

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.39

Net MarginNet income as percentage of revenue

Operating MarginOperating income as percentage of revenue

ROEReturn on shareholders' equity

ROAReturn on total assets

ROCEReturn on capital employed

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

Cash/ShareCash and equivalents per share

$0.34

FCF YieldFree cash flow as percentage of market cap

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for 9939.HKFinancial Ratios Analysis details for 9939.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for 9939.HKSector Benchmarking details for 9939.HK are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Kintor Pharmaceutical Limited Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Kintor Pharmaceutical Limited. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Kintor Pharmaceutical Limited's unique business strengths and challenges.

Key Financial Metrics for Kintor Pharmaceutical Limited

For Kintor Pharmaceutical Limited, essential financial indicators include EPS -0.39, PE -5.46, and ROE -. These key ratios reveal insights into Kintor Pharmaceutical Limited's profitability, valuation, and operational health. Understanding these metrics enables you to compare Kintor Pharmaceutical Limited with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Kintor Pharmaceutical Limited

Metrics like Net Margin - and ROA - shed light on how well Kintor Pharmaceutical Limited is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Kintor Pharmaceutical Limited can sustain its operations and continue growing in the future.

Valuation and Market Position of Kintor Pharmaceutical Limited

Using ratios such as P/B Ratio 2.85 and PEG Ratio -, investors can assess whether Kintor Pharmaceutical Limited is appropriately valued based on its financials and growth potential. These figures, combined with Kintor Pharmaceutical Limited's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Kintor Pharmaceutical Limited

Financial health indicators, such as Debt/Equity Ratio 0.45 and Cash Flow -, provide a snapshot of Kintor Pharmaceutical Limited's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Kintor Pharmaceutical Limited, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Kintor Pharmaceutical Limited

Investing in Kintor Pharmaceutical Limited based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Kintor Pharmaceutical Limited focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;